(2004)
Mechanistic implications of Escherichia coli galactokinase structure-based engineering.
Chembiochem 5,
989-992.
Publications
(2004)
Rational saccharide extension by using the natural product glycosyltransferase LanGT4.
Chembiochem 5,
369-371.
(2004)
Structure-based enzyme engineering and its impact on in vitro glycorandomization.
Chembiochem 5,
16-25.
(2003)
The C-Glycosyltransferase UrdGT2 is unselective toward d- and l-configured nucleotide-bound rhodinoses.
J Am Chem Soc 125,
4678-4679.
(2003)
Creation of the first anomeric D/L-sugar kinase by means of directed evolution.
Proc Natl Acad Sci U S A 100,
13184-13189.
(2003)
Procaryotic and eucaryotic cells in biotech production
In: Kayser O, Müller R. H. (eds.) Pharmaceutical Biotechnology, Drug Discovery and Clinical Applications pp. 9-33. Wiley-Blackwell.
(2003)
Production of landomycins in Streptomyces globisporus 1912 and S cyanogenus S136 is regulated by genes encoding putative transcriptional activators.
FEMS Microbiol Lett 222,
149-153.
(2003)
Urdamycin L: a novel metabolic shunt product that provides evidence for the role of the urdM gene in the urdamycin A biosynthetic pathway of Streptomyces fradiae TU 2717.
Chembiochem 4,
109-111.
(2002)
Engineered urdamycin glycosyltransferases are broadened and altered in substrate specificity.
Chem Biol 9,
287-295.
(2001)
Two sequence elements of glycosyltransferases involved in urdamycin biosynthesis are responsible for substrate specificity and enzymatic activity.
Chem Biol 8,
557-567.